Items tagged with Access
Life-saving TB drug is now cheaper in South Africa, but not as cheap as it can be (post)
The South African government and pharmaceutical company Johnson & Johnson (J&J) have agreed to a lower price for bedaquiline, a medicine used to treat drug-resistant tuberculosis (DR-TB) in South Africa.
TB Alliance applauds Macleods’ launch of a key component of WHO-recommended drug-resistant TB treatment regimen (post)
Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines.
New drug-resistant TB treatments reach patients in Pakistan as Association for Social Development accelerates pilot implementation (post)
ISLAMABAD and PRETORIA (9 November 2023)—The Association for Social Development (ASD) has registered 206 participants with drug-resistant tuberculosis (DR-TB) in Pakistan through a pilot program for treatment with new regimens recently recommended by the World Health Organization (WHO), known as BPaL/M – combinations of bedaquiline, pretomanid, and linezolid, with or without moxifloxacin. ASD reported that out of 113 treatment outcomes declared, so far 105 (95%) have been successful—matching the success rates found elsewhere in the world with these new regimens and a drastic improvement over results with prior drug-resistant TB therapies. As an outcome of these positive results, Pakistan has updated its treatment guidelines for DR-TB to enable the use of these six-month, all-oral regimens.
World Diabetes Day 2023: Equitable access to care for people with TB and diabetes (post)
13 November 2023 | Geneva -- In advance of the World Diabetes Day, which is marked on November 14, WHO is highlighting the need for equitable access to essential care for people affected by diabetes and tuberculosis (TB). Equitable access to care is essential to ending TB, as highlighted in WHO’s End TB Strategy and reinforced in the political declarations of the United Nations high-level meetings on the fight against TB in 2018 and 2023. According to the 2023 WHO Global TB Report, diabetes is one of the key determinants of TB, with just under 400,000 TB episodes attributable to diabetes worldwide. People with diabetes are at higher risk of developing TB and are more likely to experience poor TB treatment outcomes, including death. This emphasises the need for ensuring access to comprehensive care for people affected by both diabetes and TB.
How governments and global aid agencies use TB as a political tool (post)
As yet another conference kicks off, it underscores the way such collaborations to end the infectious disease only serve to maintain the colonial status quo.
Webinar: Time for $5 Campaign - A call on Cepheid to drop the price of GeneXpert to $5 (post)
RESIST-TB will host a webinar on 7 December 2023 'Time for $5 Campaign - A call on Cepheid to drop the price of GeneXpert to $5'.
New child-friendly formulation of rifapentine for short course TB prevention treatment now available as Unitaid and IMPAACT4TB launch an early market access vehicle (post)
More than 2 million children and adolescents lack preventive treatment for TB, which is needed for those living with HIV or exposed to TB at home.
TB and inequality: How race, caste, and class impact access to medicines (post)
The elimination of TB cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan.
Webinar: Time for $5 Campaign update (post)
Médecins Sans Frontières (MSF) Access Campaign will host a webinar on 5 March 2024 to provide an update about the next phase of escalation of the Time for $5 Campaign.
New technology enables Philippines to bring TB diagnosis closer to people (post)
The Philippines has the fourth highest TB burden in the world and contributes 7% of global cases, behind India (27%), Indonesia (10%), and China (7.1%), according to the World Health Organization’s Global TB Report 2021. But for the archipelagic country with 7,640 islands, citizens’ access to healthcare and diagnostic tools has been one of the greatest barriers to addressing TB.
Page 51 of 81 · Total posts: 0
←First 50 51 52 Last→